Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Tyagi

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Molecular Microbiology|March 31, 2004
Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene setRonggai Sun, Paul J Converse, Chiew Ko, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2013
Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitorShashank Gupta, Sandeep Tyagi, Deepak V Almeida, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosisEric Nuermberger, Sandeep Tyagi, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinationsClaire Andréjak, Deepak V Almeida, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy StudiesNan Zhang, Natasha Strydom, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosisDeepak Almeida, Eric Nuermberger, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosisSandeep Tyagi, E Nuermberger, T Yoshimatsu, et al.
The Journal of Antimicrobial Chemotherapy|November 7, 2012
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapyClaire Andréjak, Deepak V Almeida, Sandeep Tyagi, et al.
Plos Neglected Tropical Diseases|March 8, 2013
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans diseaseDeepak V Almeida, Paul J Converse, Si-Yang Li, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of TuberculosisSi-Yang Li, Rokeya Tasneen, Sandeep Tyagi, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Molecular Microbiology|March 31, 2004
Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene setRonggai Sun, Paul J Converse, Chiew Ko, et al.
American Journal of Respiratory and Critical Care Medicine|June 29, 2013
Acceleration of tuberculosis treatment by adjunctive therapy with verapamil as an efflux inhibitorShashank Gupta, Sandeep Tyagi, Deepak V Almeida, et al.
Antimicrobial Agents and Chemotherapy|February 21, 2008
Powerful bactericidal and sterilizing activity of a regimen containing PA-824, moxifloxacin, and pyrazinamide in a murine model of tuberculosisEric Nuermberger, Sandeep Tyagi, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|January 28, 2015
Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinationsClaire Andréjak, Deepak V Almeida, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|January 8, 2020
Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy StudiesNan Zhang, Natasha Strydom, Sandeep Tyagi, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2009
Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosisDeepak Almeida, Eric Nuermberger, Rokeya Tasneen, et al.
Antimicrobial Agents and Chemotherapy|May 27, 2005
Bactericidal activity of the nitroimidazopyran PA-824 in a murine model of tuberculosisSandeep Tyagi, E Nuermberger, T Yoshimatsu, et al.
The Journal of Antimicrobial Chemotherapy|November 7, 2012
Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapyClaire Andréjak, Deepak V Almeida, Sandeep Tyagi, et al.
Plos Neglected Tropical Diseases|March 8, 2013
Bactericidal activity does not predict sterilizing activity: the case of rifapentine in the murine model of Mycobacterium ulcerans diseaseDeepak V Almeida, Paul J Converse, Si-Yang Li, et al.
Antimicrobial Agents and Chemotherapy|June 21, 2017
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of TuberculosisSi-Yang Li, Rokeya Tasneen, Sandeep Tyagi, et al.
Pageof 8